Growth Metrics

Soleno Therapeutics (SLNO) Other Gross PP&E Adjustments: 2013-2018

  • Soleno Therapeutics' Other Gross PP&E Adjustments fell 42.62% to $35,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $486,045, marking a year-over-year decrease of 27.41%. This contributed to the annual value of $35,000 for FY2018, which is 42.62% down from last year.
  • Latest data reveals that Soleno Therapeutics reported Other Gross PP&E Adjustments of $35,000 as of Q4 2018, which was down 42.62% from $61,000 recorded in Q4 2017.
  • Soleno Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $297,595 for Q4 2015, and its period low was $35,000 during Q4 2018.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was $61,000 (2017), whereas its average is $62,817.
  • As far as peak fluctuations go, Soleno Therapeutics' Other Gross PP&E Adjustments skyrocketed by 36.19% in 2015, and later crashed by 68.93% in 2016.
  • Soleno Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $218,519 in 2014, then soared by 36.19% to $297,595 in 2015, then slumped by 68.93% to $92,450 in 2016, then plummeted by 34.02% to $61,000 in 2017, then crashed by 42.62% to $35,000 in 2018.
  • Its Other Gross PP&E Adjustments was $35,000 in Q4 2018, compared to $61,000 in Q4 2017 and $92,450 in Q4 2016.